Global Wound Debridement Products Industry

News provided by

Jun 26, 2014, 11:37 ET

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Global Wound Debridement Products Industry

http://www.reportbuyer.com/pharma_healthcare/medical_supplies/hospital_supplies/global_wound_debridement_products_industry.html

This report analyzes the worldwide markets for Wound Debridement Products in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 35 companies including many key and niche players such as -

Advanced Medical Solutions Group plc
ArthroCare Corporation
Coloplast A/S
Derma Sciences, Inc.
Misonix, Inc.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Wound Debridement Products I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Wounds: A Prelude II-1
Wound Debridement - Market Overview II-1
Prevalence and Incidence of Wounds - Select Statistics II-2
Table 1: Global Prevalence of Wounds (2013) (includes
corresponding Graph/Chart) II-2
Chronic Wounds: The Hard Numbers II-2
Table 2: Incidence of Open Wounds in Select Countries (2013) II-3

2. MARKET TRENDS AND ISSUES II-4
Growing Incidence of Hard to Heal Wounds - A Key Growth Driver II-4
Rising Prevalence of Diabetes Escalates Incidence of Chronic
Wounds II-4
Table 3: Worldwide Prevalence of Diabetes Mellitus by
Region: 2013 & 2035 (includes corresponding Graph/Chart) II-6

Table 4: Incidence of Diabetes in Select Countries (2013 &
2035) (includes corresponding Graph/Chart) II-6
Increasing Acceptance of Wound Bed Preparation Methods Fuels
Demand II-7
Maintenance Debridement Sustains Adoption of Debridement
Products/Techniques II-7
Advanced Debridement Products to Turbo Charge Market Growth II-7
Monofilament Polyester Fibre Pad II-8
Plasma-Mediated Bipolar Radio Frequency Ablation II-8
Hydrosurgery II-8
Ultrasound II-8
Honey as a Debridement Agent Gains Prominence II-9
Larvae Therapy - A High Potential Debridement Method II-9
Increasing Focus on Reducing Hospital Stays Lends Traction II-10
Expanding Aging Population Spurs Demand II-10
Table 5: Elderly Population (60+ Years) as a Percentage of
the Total Population: 2012 & 2050 (includes corresponding
Graph/Chart) II-11

Table 6: Global Aging Population (over the age of 60) and
their Proportion of Total Population (2012) (includes
corresponding Graph/Chart) II-12

Table 7: Life Expectancy at Age 60 and 80 Years -
(2010-2015), (2020-2025) & (2045-2050) (includes
corresponding Graph/Chart) II-13
Increasing Obesity Levels Underpins Market Growth II-13
Table 8: Global Obesity Population (2013) (includes
corresponding Graph/Chart) II-14

Table 9: Prevalence of Adult Obesity in Select Countries
(2012) (includes corresponding Graph/Chart) II-14
Impact of New Medicare Reimbursement Policy on US Wound
Debridement Market II-15
Table 10: 2014 vs. 2013 Average Medicare Allowable Rates for
HOPDs for Debridement Procedures II-15
Developed Countries Maintain Stronghold, Asia-Pacific to Lead
Growth II-16

3. PRODUCT OVERVIEW II-17
Debridement II-17
Purpose of Debridement II-17
Factors Influencing Debridement Decision II-18
Methods/Techniques of Debridement II-18
Selective Methods II-18
Larvae Debridement Therapy/Bio-Surgical Debridement/
Biological Debridement II-18
Chemical/Enzymatic Debridement II-19
Autolytic Debridement II-19
Non-Selective Methods II-19
Mechanical Debridement II-19
Sharp and Surgical Debridement II-20
Ultrasound II-20
Types of Wounds II-20
Acute Wounds II-20
Surgical Incisions II-20
Burns II-21
Chemical Burns II-21
Electrical Burns II-21
Flash Burns II-21
Radiation Burns II-22
Thermal Burns II-22
Chronic Wounds II-22
Diabetic Ulcers II-22
Venous Ulcers II-22
Pressure Ulcers II-23
Process of Wound Care II-23
Preparation II-23
Controlling Bleeding II-23
Irrigation and Cleaning II-23
Closure II-23
Infection Control II-23
Wound Healing Process II-24
Injury II-24
Inflammatory Response II-24
Coagulation Cascade II-24
Vasodilation II-25
Cellular Activity II-25
Debridement, Cell Growth and Healing II-26
Scarring II-26
Abnormal Scarring II-26
Fetal Wound Healing II-26

4. STRATEGIC CORPORATE DEVELOPMENTS II-27
Alliqua Inks Distribution Agreement with McKesson Medical-
Surgical II-27
SteadMed Medical Signs Agreement with PuriCore for
Distribution of Vashe Wound Therapy II-27
Smith & Nephew Acquires Healthpoint Biotherapeutics II-27
EMA Recommends NexoBrid for Treatment of Burns II-27
NovaBay Pharmaceuticals' NeutroPhase® Wound Cleanser Receives
FDA 510 (k) Clearance II-28
Misonix and SIAD Healthcare Renew Distribution Agreement II-28
Cardium Inks Agreement with Angel II-28
Misonix Inks Agreement with Technical Communities II-29
IrriMax Inks Supplier Contract with Premier II-29
PuriCore Launches Vashe Wound Therapy II-29
Smith & Nephew Launches VERSAJET II Hydrosurgery System II-29
Misonix Adds SonicOneA® Technology to BoneScalpel™ Platform II-30
IrriMax Launches IrriSept® Wound Cleansing and Debridement System II-30
Healthpoint Biotherapeutics to Unveil Collagenase SANTYL®
Ointment II-30
ArthroCare Introduces WoundWand Debridement Care Device II-31
Spring Creek Inks Licensing Contract with McCoy Enterprises II-31
Misonix Signs Exclusive Distribution Agreement with EuroTech™ II-31

5. FOCUS ON SELECT GLOBAL PLAYERS II-32
Advanced Medical Solutions Group plc (UK) II-32
ArthroCare Corporation (US) II-32
Coloplast A/S (Denmark) II-32
Derma Sciences, Inc. (US) II-32
Misonix, Inc. (US) II-33
PuriCore plc (US) II-33
Smith & Nephew Plc (UK) II-33
MediWound Ltd. (Israel) II-34

6. GLOBAL MARKET PERSPECTIVE II-35
Table 11: World Recent Past, Current & Future Analysis for
Wound Debridement Products by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Latin America
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2012 through 2020
(includes corresponding Graph/Chart) II-35

Table 12: World Historic Review for Wound Debridement Products
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2006 through 2011 (includes corresponding
Graph/Chart) II-36

Table 13: World 15-Year Perspective for Wound Debridement
Products by Geographic Region - Percentage Breakdown of Sales
for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Latin America and Rest of World Markets for Years 2006, 2014 &
2020 (includes corresponding Graph/Chart) II-37
European Market by Region/Country II-38
Table 14: European Recent Past, Current & Future Analysis for
Wound Debridement Products by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousand for Years 2012 through 2020 (includes corresponding
Graph/Chart) II-38

Table 15: European Historic Review for Wound Debridement
Products by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2006 through 2011 (includes corresponding Graph/Chart) II-39

Table 16: European 15-Year Perspective for Wound Debridement
Products by Geographic Region - Percentage Breakdown of Sales
for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2006, 2014 & 2020 (includes
corresponding Graph/Chart) II-40
Asia-Pacific Market by Region/Country II-41
Table 17: Asia-Pacific Recent Past, Current & Future Analysis
for Wound Debridement Products by Geographic Region - China,
India and Rest of Asia-Pacific Markets Independently Analyzed
with Annual Sales Figures in US$ Thousand for Years 2012
through 2020 (includes corresponding Graph/Chart) II-41

Table 18: Asia-Pacific Historic Review for Wound Debridement
Products by Geographic Region - China, India and Rest of
Asia-Pacific Markets Independently Analyzed with Annual Sales
Figures in US$ Thousand for Years 2006 through 2011 (includes
corresponding Graph/Chart) II-42

Table 19: Asia-Pacific 15-Year Perspective for Wound
Debridement Products by Geographic Region - Percentage
Breakdown of Sales for China, India and Rest of Asia-Pacific
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-43
Latin American Market by Region/Country II-44
Table 20: Latin American Recent Past, Current & Future
Analysis for Wound Debridement Products by Geographic Region -
Brazil and Rest of Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Thousand for Years
2012 through 2020 (includes corresponding Graph/Chart) II-44

Table 21: Latin American Historic Review for Wound
Debridement Products by Geographic Region - Brazil and Rest
of Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Thousand for Years 2006 through 2011
(includes corresponding Graph/Chart) II-45

Table 22: Latin American 15-Year Perspective for Wound
Debridement Products by Geographic Region - Percentage
Breakdown of Sales for Brazil and Rest of Latin America
Markets for Years 2006, 2014 & 2020 (includes corresponding
Graph/Chart) II-46

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 35 (including Divisions/Subsidiaries - 46)

The United States (31)
Canada (2)
Europe (10)
- Germany (2)
- The United Kingdom (5)
- Italy (1)
- Rest of Europe (2)
Asia-Pacific (Excluding Japan) (2)
Middle East (1)